Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in antimicrobial therapy with beta-lactam antibiotics.

T R Beam

    Journal of Medicine
    |January 1, 1983
    PubMed
    Summary

    Six new penicillin and cephalosporin antibiotics offer expanded antibacterial activity, showing promise in treating gram-negative meningitis. Their unique profiles require individual assessment for optimal therapeutic use.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Panel discussion: morning session.

    Bulletin of the New York Academy of Medicine·2009
    Same author

    Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.

    The Journal of infectious diseases·1996
    Same author

    In-vitro activity of trospectromycin against gram-positive cocci.

    The Journal of antimicrobial chemotherapy·1995
    Same author

    Anti-infective drugs in the prevention and treatment of sepsis syndrome.

    Critical care nursing clinics of North America·1994
    Same author

    Susceptibility of bacteraemic isolates of gram-positive cocci to daptomycin and other antimicrobial agents.

    The Journal of antimicrobial chemotherapy·1994
    Same author

    European guidelines for anti-infective drug products. Introduction.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1993

    Area of Science:

    • Pharmacology
    • Microbiology
    • Medicinal Chemistry

    Background:

    • The development of novel antibiotics is crucial for combating evolving bacterial resistance.
    • Penicillin and cephalosporin classes remain vital in antibacterial therapy.
    • Biochemical modifications of the beta-lactam ring have led to new drug candidates.

    Purpose of the Study:

    • To introduce and characterize six new penicillin and cephalosporin compounds available in the United States.
    • To highlight the expanded antibacterial spectrum and unique profiles of these novel agents.
    • To provide guidance for distinguishing between these new antibiotics based on key properties.

    Main Methods:

    • Biochemical manipulation of the beta-lactam ring and adjacent chemical groups.
    • Evaluation of the antibacterial spectrum of activity for each new compound.
    • Assessment of therapeutic efficacy, particularly in gram-negative meningitis.
    • Analysis of pharmacokinetic and toxicologic properties.

    Main Results:

    • Three new penicillin and three new cephalosporin compounds have been developed and are available.
    • These agents exhibit a greatly expanded spectrum of antibacterial activity.
    • Successful therapeutic outcomes were observed in treating gram-negative meningitis.
    • The prophylactic use of these antibiotics in surgery remains a subject of debate.

    Conclusions:

    • The six new agents possess unique antimicrobial profiles necessitating independent evaluation.
    • These novel antibiotics represent significant advancements in treating serious bacterial infections.
    • Guidelines are provided to aid clinicians in selecting the appropriate agent based on antimicrobial, pharmacokinetic, and toxicologic data.

    Related Experiment Videos